← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2005First marketed drug
Jan 18, 2011First NDA
Jan 18, 2011Last known activity
Mar 4, 2022
Timeline
2000s
- Jan 1, 2002
ParaPro— Founded
2010s
- Jan 18, 2011
spinosad— NDA Organization
Drugs by trial phase (3 distinct, 12 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (1)
Recent trials (16)
- NCT05310734Lead sponsorPhase 4Mar 4, 2022
- NCT05310734Study directorPhase 4Mar 4, 2022
- NCT05310734OfficialPhase 4Mar 4, 2022
- NCT02485704Lead sponsorPhase 3May 10, 2017
- NCT02485704Study directorPhase 3May 10, 2017
- NCT02485717Lead sponsorPhase 3May 2, 2017
- NCT02485717Study directorPhase 3May 2, 2017
- NCT01660321Lead sponsorPhase 4Sep 1, 2011
- NCT00605956Lead sponsorPhase 1Jan 1, 2008
- NCT00591331Lead sponsorPhase 1Dec 1, 2007
- NCT00545168Lead sponsorPhase 3Sep 1, 2007
- NCT00545753Lead sponsorPhase 3Sep 1, 2007
- NCT00857935Lead sponsorPhase 2Mar 1, 2007
- NCT00410709Lead sponsorPhase 1Dec 1, 2006
- NCT00311779Lead sponsorPhase 2Mar 1, 2006
Details
- Founded
- Carmel, IN, US Jan 1, 2002
- First NDA
- Jan 18, 2011
- Last known activity
- Mar 4, 2022